Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by august202013on Oct 16, 2023 9:17am
148 Views
Post# 35685033

WORTH THE WAIT FOR END JULY YEAR END FIN BY 30-11 (120 DAYS)

WORTH THE WAIT FOR END JULY YEAR END FIN BY 30-11 (120 DAYS)THANK YOU TMMM2023 FOR UPDATES BUT STILL BELIEVE MM SAID LAST YEAR OR BEFORE WAS 90 DAYS
BUT CORRECT PER TXS RULE 120 DAYS FOR VENTURE..

WORTH THE WAIT (NO CHOICE) FOR POSSIBILITY OF HC PER LATEST UPDATES (27-9-2023) ANNOUNCEMENT AND

31-7-2023 YEAR END FINANCIAL FROM 30 YEAR OLD INFANT DUE BY END NOVEMBER, 2023. SAD BECAUSE AFTER 30 YEARS AND TWO PANDERMIC SARS AND COVID19 STILL HAVE TO CLAIM TO BE AN INFANT(TSX VENTURE)..

HAVE TO ACCEPT FACT THAT STILL INFANCY STAGES BECAUSE TOO MANY SUBSIDIARIES ALL OVER THE WORLD WHICH NEED TO BE CONSOLIDATED UNLIKE NVI.....DIA HAVE ALL THE ACCOUNTANTS MIR ONLY HAS ONE.       
<< Previous
Bullboard Posts
Next >>